- Home
- GPRO vs NKTR Comparison
GPRO vs NKTR Comparison
Compare GPRO & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- NKTR
- Stock Information
- Founded
- GPRO 2004
- NKTR 1990
- Country
- GPRO United States
- NKTR United States
- Employees
- GPRO N/A
- NKTR N/A
- Industry
- GPRO Industrial Machinery/Components
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- GPRO Consumer Discretionary
- NKTR Health Care
- Exchange
- GPRO Nasdaq
- NKTR Nasdaq
- Market Cap
- GPRO 102.2M
- NKTR 108.3M
- IPO Year
- GPRO 2014
- NKTR 1994
- Fundamental
- Price
- GPRO $0.72
- NKTR $24.31
- Analyst Decision
- GPRO Hold
- NKTR Strong Buy
- Analyst Count
- GPRO 1
- NKTR 6
- Target Price
- GPRO $1.50
- NKTR $77.50
- AVG Volume (30 Days)
- GPRO 5.2M
- NKTR 4.4M
- Earning Date
- GPRO 08-05-2025
- NKTR 08-07-2025
- Dividend Yield
- GPRO N/A
- NKTR N/A
- EPS Growth
- GPRO N/A
- NKTR N/A
- EPS
- GPRO N/A
- NKTR N/A
- Revenue
- GPRO $780,312,000.00
- NKTR $87,248,000.00
- Revenue This Year
- GPRO N/A
- NKTR N/A
- Revenue Next Year
- GPRO $6.79
- NKTR N/A
- P/E Ratio
- GPRO N/A
- NKTR N/A
- Revenue Growth
- GPRO N/A
- NKTR N/A
- 52 Week Low
- GPRO $0.40
- NKTR $6.48
- 52 Week High
- GPRO $1.76
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- GPRO 45.53
- NKTR 68.55
- Support Level
- GPRO $0.67
- NKTR $8.27
- Resistance Level
- GPRO $0.95
- NKTR $37.38
- Average True Range (ATR)
- GPRO 0.07
- NKTR 3.54
- MACD
- GPRO -0.02
- NKTR 1.72
- Stochastic Oscillator
- GPRO 20.40
- NKTR 55.75
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.